Dr. Richard Toselli, CEO of the InVivo Therapeutics Corporation a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries joins eHealth Radio and the Health News & Spinal Health Channels.
Listen to interview with host Eric Michaels and guest Dr. Richard Toselli discuss the following:
Prior to joining InVivo, Dr. Toselli served as Chief Medical Officer for Cochlear Limited. In that role, he was responsible for global clinical, regulatory, and medical affairs teams reporting to the CEO. Prior to that, Dr. Toselli served five years at Sanofi in various levels of increasing responsibility, including Vice President of Global Medical Affairs – Immunology and Inflammation, Biologics Division; Vice President of Global Medical Affairs and Head of the Biosurgery Discovery Performance Unit; and Vice President of Global Medical Affairs, Biosurgery.
Before his time at Sanofi, he served as Chief Medical/Technology Officer for Covidien Surgical, and earlier held various roles at DePuy Spine including Director of Medical Affairs, Worldwide Vice President of Research and Development, and Worldwide Vice President of Clinical Evidence and External Relations. He subsequently held the position of Vice President of Evidence-Based Medicine at Johnson & Johnson for the device sector.
Dr. Toselli’s previous academic positions include Assistant Professor at Brown University, Associate Professor, Director of Spine Center, and Associate Chief of Staff at the University of North Carolina (UNC), and Associate Professor at the University of Vermont. He holds a bachelor of arts from Providence College, his medical degree from Brown University, and a masters of business administration from the UNC’s Kenan-Flagler Business School. Dr. Toselli is a board-certified neurological surgeon.
InVivo Therapeutics Holdings Corporation is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. The company was founded in 2005 with proprietary technology co-invented by Robert Langer, Sc.D., Professor at Massachusetts Institute of Technology, and Joseph P. Vacanti, M.D., who then was at Boston Children’s Hospital and who now is affiliated with Massachusetts General Hospital. In January 2018, the company announced updated clinical evidence, including improvements in patients with acute spinal cord injury (SCI), from its INSPIRE study of the Neuro-Spinal Scaffold™. The publicly traded company is headquartered in Cambridge, MA.
Website: www.invivotherapeutics.com
How Do People with Less Stress Differ from Those with More?
Eddie Witz’ Musical Journey to Health
How to Center and Ground Yourself Amid Chaos
Bad Habits We Can Break That Are Linked to Depression and or Anxiety
Among First Plastic Surgeons to Add the Innovative Ellacor Micro-Coring Treatment to His Practice
The “Awake” Facelift with Dr. Stephanie Teotia
Potential Romantic/Sexual Encounters After Disclosing Vulnerable Information to You
Revolutionize Your Health with Agatha Achindu
It’s NOT the Medication, It’s the Motivation!
A Candid Conversation with a distinguished dentist, Dr. Jamie Chan
Changing the Way We Think About Asking for Help!
The Lost Coin: A Therapist’s Personal Adoption Journey and Insights
Telemedicine: The Long-Term Solution to Physician Shortages and Specialty Coverage
Transform an Uncontrolled Mind into a Creative Mind in 4 Simple Steps
Fight Against Domestic Violence and Assault
Philanthropic Pursuits and Extreme Athletic Achievements
Access to Red Light Therapy Treatment Conveniently and Efficiently
The ever growing numbers of depression and anxiety
Interview with Alex Kleinman, Senior Vice President, Global Segment Leader of Healthcare at Genpact
Discovering emotional scars that can run our lives
Join Podbean Ads Marketplace and connect with engaged listeners.
Advertise Today
Create your
podcast in
minutes
It is Free
The Relaxback UK Show
Good Nurse Bad Nurse
On Call With Dr. Anselm Anyoha
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive